KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Amortization of Deferred Charges (2016 - 2018)

Historic Amortization of Deferred Charges for Medtronic (MDT) over the last 4 years, with Q2 2018 value amounting to $4.0 million.

  • Medtronic's Amortization of Deferred Charges rose 14000.0% to $4.0 million in Q2 2018 from the same period last year, while for Apr 2018 it was -$13.0 million, marking a year-over-year decrease of 21818.18%. This contributed to the annual value of -$13.0 million for FY2018, which is 21818.18% down from last year.
  • As of Q2 2018, Medtronic's Amortization of Deferred Charges stood at $4.0 million, which was up 14000.0% from $3.0 million recorded in Q1 2018.
  • Medtronic's Amortization of Deferred Charges' 5-year high stood at $8.0 million during Q4 2015, with a 5-year trough of -$10.0 million in Q2 2017.
  • Its 4-year average for Amortization of Deferred Charges is $2.2 million, with a median of $7.0 million in 2015.
  • As far as peak fluctuations go, Medtronic's Amortization of Deferred Charges crashed by 24285.71% in 2017, and later surged by 14000.0% in 2018.
  • Medtronic's Amortization of Deferred Charges (Quarter) stood at $8.0 million in 2015, then fell by 12.5% to $7.0 million in 2016, then tumbled by 242.86% to -$10.0 million in 2017, then surged by 140.0% to $4.0 million in 2018.
  • Its Amortization of Deferred Charges was $4.0 million in Q2 2018, compared to $3.0 million in Q1 2018 and -$10.0 million in Q4 2017.